At least one million people will die in sub-Saharan Africa and elsewhere, researchers and advocates said on Tuesday, if funding cuts proposed by the Trump administration to global public health programs are enacted

Quick Read

Aetna, one of the nation’s largest insurance companies, will remove a key barrier for patients seeking medication to treat opioid addiction. The change will take effect in March and apply to commercial plans, a company spokeswoman confirmed, and will make it the third major insurer to make the switch

Quick Read

A one-off injection could one day lower your cholesterol levels for the rest of your life. People born with natural mutations that disable a specific gene have a lower risk of heart disease, with no apparent side effects. Now a single injection has successfully disabled this same gene in animal tests for the first time

Quick Read

The bodies just keep arriving. On Thursday, only two days into February, the coroner’s office in Dayton, Ohio, had already handled 25 deaths — 18 caused by drug overdoses. In January, the office processed 145 cases in which the victims’ bodies had been destroyed by opioids

Quick Read

Our Travis Rieder discusses challenges with our healthcare system and prescription opioids based on his personal experiences

Quick Read

Every year in the U.S., more than 30,000 people die from things related to guns. That puts guns ahead of HIV, Parkinson’s disease, malnutrition, hypertension, intestinal infection, peptic ulcer, anemia, viral hepatitis, biliary tract disease, atherosclerosis and fires. Yet, the funding for research on gun violence lags far behind other leading causes of death, according to a study published Tuesday in JAMA

Quick Read

The opioid crisis sweeps through Cherokee Nation. Dr. Anna Miller sits with her legs pulled up, boots kicked off, in an exam chair at Cherokee Nation W.W. Hastings Hospital. She’s waiting for her first Suboxone patient of the day

Quick Read

if only we could be motivated to use them. Those are the conclusions of two new studies about the promise and perils of relying on fitness trackers to measure and guide how we move

Quick Read